【Abnova】March 2026 Revenue NT$34 Million (YoY -4.1%)
Abnova's revenue for March 2026 was NT$34 million, a decrease of 4.1% year-over-year. The company is in the Biotechnology and Medical Care industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 21:27 (4h 57m after Collected)
Company Ticker: 4133
Company Name: Abnova
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 34,395 thousand TWD (34 million)
Year-over-Year Change: -4.1%
Company Name: Abnova
Industry: Biotechnology and Medical Care
Data Month: 2026-03
Monthly Revenue: 34,395 thousand TWD (34 million)
Year-over-Year Change: -4.1%
FAQ
What was Abnova's revenue in March 2026?
It was TWD 34.4 million, a decrease of 4.1% year-over-year.
What does Abnova sell?
It sells antibodies, proteins, and reagent kits online for use by researchers at universities and pharmaceutical companies.
How should we view Abnova's performance?
Since monthly sales are influenced by how its customers spend their research budgets, it needs to be viewed from a longer-term perspective (quarterly or full-year).